Looking forward, DexCom's management has reiterated its fiscal year 2025 forecast, anticipating revenue growth of 14% with a ...

A U.K. court has ruled against Abbott in a trademark infringement case the company had brought over the design of a rival ...

We recently published a list of 15 Best Dividend Stocks To Buy and Hold. In this article, we are going to take a look at ...

Since the start of 2025, Medtronic plc (NYSE:MDT) has surged by over 13%. Earlier this year, the company received US approval for its Simplera continuous glucose monitoring (CGM) system.

Introduction to Digital Health and WellnessThe digital health and wellness industry is experiencing significant growth as healthcare increasingly incorporates technology to improve the quality, ...

The On-Body Drug Delivery Devices market is witnessing significant growth, driven by the increasing demand for ...

Medtronic develops innovative insulin pumps and pens, continuous glucose monitoring devices, and more. Given that there are half a billion adults worldwide with diabetes, the majority of whom don ...

Continuous glucose monitors can predict some imminent hypoglycemic episodes ... the Juvenile Diabetes Research Foundation, Medtronic, Merck, the National Institutes of Health, Novo Nordisk, Sanofi, ...